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Association Between HLA-DM and HLA-DR In Vivo
Frances Sanderson,* Claire Thomas,* the class II region of the MHC by a gene linked to conven-
tional class II loci, HLA-DR, HLA-DQ, and HLA-DP (KellyJacques Neefjes,² and John Trowsdale*
*Human Immunogenetics Laboratory et al., 1991). HLA-DM has a number of unique character-
istics, indicating that its function may be somewhat dif-Imperial Cancer Research Fund
44 Lincolns Inn Fields ferent to that of ordinary class II molecules. It colocalizes
with HLA-DR to the MIICs of antigen-presenting cellsHolborn
London WC2A 3PX (APCs) but, unlike classical class II molecules, does not
accumulate at the cell surface (Karlsson et al., 1994;United Kingdom
²Netherlands Cancer Institute Sanderson et al., 1994). The key role of HLA-DM in class
II antigen processing was elucidated by the discoveryPlasmanlaan 121
1066 CX Amsterdam that the defect in a group of antigen-processing mutant
cell lines was due to disruption of either DMA or DMBThe Netherlands
loci (Fling et al., 1994; Morris et al., 1994). In the mutant
cells, surface class II molecules are present at wild-
type levels but lack the expression of certain antibody
Summary epitopes and have lost the SDS stability normallyassoci-
ated with antigenic peptide binding (Mellins et al., 1990;
The exchange of HLA class II±associated invariant Riberdy and Cresswell, 1992). In fact, HLA-DR molecules
chain peptides (CLIP) for cognate peptide is catalyzed in DM-deficient cell lines are unable to present intact
by HLA-DM under acidic conditions in vitro by an un- protein antigen and are mainly occupied not with anti-
known mechanism. Here, we show an association be- genic peptides, but with fragments (81±105) of the class
tween HLA-DM and HLA-DR in vivo by coprecipitation II±associated Ii chain, termed CLIP (Avva and Cresswell,
of the two heterodimers. The association is favored 1994; Riberdy et al., 1992; Sette et al., 1992). Reintroduc-
at low pH and in the nonionic detergent digitonin. Most tion of DM genes into mutant cells results in the loss
DM±DR complexes are isolated from dense subcellu- of CLIP and acquisition of cognate peptide by class II
lar fractions. Recovery of HLA-DM by the conforma- molecules (Denzin et al., 1994). Class II abCLIP can be
tion-dependent DR3 monoclonal antibody 16.23 sug- generated from abIi in vitro by incubating the purified
gests an association with HLA-DR heterodimers complexes with endosomal proteases (Avva and Cress-
beyond the stage at which CLIP is released. The addi- well, 1994). A similar process may operate in vivo to
tional N-linked glycan on mutant DR3 molecules iso- produce the abCLIP identified as a biosynthetic interme-
lated from the 10.24.6 cell line, which interferes with diate in wild-type cells (Cresswell, 1994).
DM-enhanced CLIP release from DR3 in vitro, also Several models have been proposed to explain the
affects the DM±DR interaction. loss of CLIP and acquisition of cognate peptide in the
presence of HLA-DM. Some of the models require a
direct interaction between HLA-DM and classical classIntroduction
II molecules, while others, notably those where HLA-
DM competes with class II for CLIP binding, do not. ToMajor histocompatibility complex (MHC) class II mole-
differentiate the various models for HLA-DM function,cules are heterodimeric cell surface glycoproteins that
and to gain further insights into its mode of action, wepresent peptides derived from extracellular pathogens
have sought to demonstrate a physical interaction be-to CD41 T cells. Shortly after biosynthesis, the a and b
tween the two molecules and to define the conditionschains of the class II molecule assemble together with a
under which it occurs. Here, we present evidence thatthird subunit, the invariant chain (Ii) to form a nonameric
direct DM±DR association does take place and is re-complex (Marks et al., 1990; Roche et al., 1991). Ii is a
stricted to a late endosomal/lysosomal compartment,nonpolymorphic protein that is important both for the
where peptide loading of MHC class II molecules isefficient assembly of the class II ab heterodimer (Ander-
thought to occur.son and Miller, 1992; Peterson and Miller, 1990) and
for directing ab to the specialized acidic MHC class
II compartment (MIIC) (Bakke and Dobberstein, 1990; Results
Lamb and Cresswell, 1992; Lotteau et al., 1990; Neefjes
et al., 1990; Peters et al., 1991). In addition, Ii prevents Specificity of the Anti-DMa MAb 5C1
We have generated a monoclonal antibody (MAb) 5C1binding of peptides to class II molecules within the endo-
plasmic reticulum (ER) (Teyton et al., 1990). Following Ii against DMa, which was then used as a tool in all of the
experiments described below. The specificity of 5C1proteolysis, the class II heterodimer becomes compe-
tent to bind antigenic peptide (Roche and Cresswell, was demonstrated on Western blots (Figure 1) by mak-
ing use of the mutant B LCL 2.2.93, which does not1990, 1991; Roche et al., 1992) and the class II±peptide
complex then travels to the cell surface (Stern et al., express DMa (Fling et al., 1994) (lanes DMa2), and
the B LCL 7.9.6 line, which does not expressDMb (Morris1994). It is now recognized that the final step of peptide
binding requires an additional protein, HLA-DM. et al., 1994) (lanes DMb2). NP40 lysates (L) or concen-
trated glycoprotein preparations (G) were analyzed onHLA-DM is a novel class II molecule encoded within
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Figure 1. Specificity of DMa MAb 5C1 on Western Blot
NP40 lysates (L) and glycoprotein preparations (G) from wild-type
and mutant B cells, were analyzed by SDS±PAGE and Western
blotting. Blots were probed with anti-DRa MAb 1B5 and anti-DMa
MAb 5C1. Cell lines used are indicated above the lanes: DMa2,
(2.2.93 B LCL mutant with point mutation in DMa), DMb2 (7.9.6 B
LCL mutant with point mutation in DMb), W/T (Raji Burkitt lymphoma
cell line). The positions of DRa and DMa are shown on the right.
Western blots and probed with either MAb 1B5 (Figure
1, top, anti-DRa) or 5C1 (bottom). 5C1 detected bands
of the appropriate molecular weight only in cells ex-
pressing DMa.
DM±DR Complexes Are Detected in
Figure 2. DM/DR Complexes Are Detected in Digitonin-SolubilizedDigitonin-Solubilized B Cells in a
B Cells in a pH-Dependent Manner
pH-Dependent Manner
(A) Raji cells were lysed in 1% digitonin (D) or 1% NP40 (N) at either
A physical interaction between HLA-DM and classical pH 5 or at pH 7 (lysis pH). The pH was adjusted after preclearing
class II molecules has been invoked in models seeking where indicated (IP pH) and immunoprecipitations were carried out
to explain the role of HLA-DM in antigen processing. To with anti-DR or anti-DMb serum. Immunoprecipitated material was
divided andanalyzed by SDS±PAGE and immunoblotting to produceinvestigate this possibility, we attempted to coprecipi-
two filters. Raji cell lysate (R) was loaded in the center of the gel astate DM and DR molecules from B cells solubilized under
a positive control. Blots were probed with 1B5 (anti DRa) and 5C1a number of different conditions. Conditions were cho-
(anti-DMa) (top and bottom, respectively). The locations of DR and
sen to reflect the anticipated weak nature of any associ- DM a chains are indicated on the right.
ation and, in view of the colocalization of the two mole- (B) Two-dimensional SDS±PAGE analysis of material precipitated
cules in lysosomal vesicles (Sanderson et al., 1994), the with anti-DR serum from Raji cells solubilized in digitonin at pH 5.
The filter was probed sequentially with 5C1 (top) and with 1B5 (bot-possibility of an effect of acidic pH on the interaction.
tom). Nonequilibrium pH gradient electrophoresis (first dimension)Raji B lymphoma cells were lysed in digitonin or in
was run from right to left, basic to acidic.NP40 and proteins were immunoprecipitated with anti-
DR or anti-DM polyclonal sera, followed by analysis by
SDS±PAGE and Western blotting. The presence of HLA-
extracts made and maintained at pH 5 (Figure 2A, top,DM or HLA-DR in the immunoprecipitates was detected
lane 9 versus lane 11). This indicated that pH affectedusing MAbs to DRa (1B5) and DMa (5C1). As shown in
the stability of the DM±DR complex and not simply theFigure 2A, the anti-DR serum precipitated DRa (top,
efficiency of the antigen±antibody interaction. The spec-lanes 1±6) and the anti-DMb serum precipitated DMa
ificity of the DM±DR interaction shown in Figure 2A was(bottom, lanes 8±13) from cells extracted in either deter-
confirmed by the absence of DMa from material precipi-gent and in a pH-independent manner. However, co-
tated by anti-class I heavy chain serum from digitoninprecipitation of HLA-DM and HLA-DR was only seen in
lysates at either pH 5 or pH 7 (data not shown).digitonin lysates. The DM±DR complexes were more
Anti-DR immunoprecipitates from digitonin-solubi-stable at pH 5: DR molecules were only recovered with
lized Raji cells were also analyzed by two-dimensionalanti-DMb from acidified lysates (Figure 2A, top, lanes 9
electrophoresis. After Western blotting, the membraneand 11) and the amount of HLA-DM coprecipitated by
was probed sequentially with MAbs 5C1 and 1B5 (Figureanti-DR serum was greater at low pH (bottom, compare
2B). MAb 5C1 (Figure 2B, top) recognized three distinctlane 4 with lanes 1±3). We noted a marked reduction in
DMa spots that migrated slightly more slowly in thethe efficiency of coimmunoprecipitation from cell ly-
second dimension and at a more acidic pI, than thesates made at pH 7 that were acidified immediately
before incubation with the anti-serum, as compared with class II a chains that were recognized by MAb 1B5.
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from the mixed lysate (bottom, lane 7; top, lane 3),
DM±DR complexes were not detected (bottom, lane 3;
top, lane 7), unless cells with a full complement of both
molecules were used (lanes 4 and 8).
DM±DR Complexes Are Found in Dense
Subcellular Fractions
Subcellular fractionation techniques have recently been
applied to the problem of class II antigen processing.
Using these techniques, class II molecules were ob-
served in lysosomal fractions within 2±3 hr of synthesis
and before their appearance at the cell surface com-
plexed to antigenic peptides (Cresswell, 1994; Germain,
1994). It is in these compartments too that class II±
peptide complexes can be first detected (Qiu et al.,
1994). HLA-DM comigrates with DR heterodimers and
lysosomal markers upon subcellular fractionation and
accumulates in the distinctive dense multilaminar com-
partment (Sanderson et al., 1994) that has been pro-
posed as the site of class II antigen loading (Peters et
al., 1991). It was therefore of interest to determine
whether the observed association between HLA-DM
and HLA-DR took place here or elsewhere in the cell.
Figure 3. DM/DR Complexes Are Not Formed in Cell Lysates In Vitro
Figure 4A shows the typical result of subcellular frac-
Mutant B cells, lacking DRa (HMy2.DRN) or DMb (7.9.6) were lysed tionation of Raji cells on a Percoll density gradient. MHC
separately or together in digitonin. Digitonin-solubilized Raji cells
class I heavy chain defines the migration on the gradientwere used as a positive control. Material immunoprecipitated by
of ER/cell surface membranes (Figure 4A, fractions 1MAb 1B5 (anti-DRa) and by AK3 (anti-DMb) from single or mixed
and 2). Both DM and DR molecules exhibited a bimodallysates was analyzed by SDS±PAGE and Western blotting. Because
of the previously established conditions under which DM and DR pattern of distribution with peaks in ER/cell surface and
can be coprecipitated by the two antibodies (see Figure 2 and text), in lysosomal fractions (9±12). The majority of HLA-DR
immunoprecipitates with 1B5 were made from pH 7 lysates, while localized to the former and HLA-DM to the latter com-
cells extracted at pH 5 were used for immunoprecipitation with AK3. partment. Class II±associated DM molecules were re-
Identical filters were probed with MAbs to DRa (1B5) or to DMa
covered in a separate experiment by immunoprecipita-(5C1), (top and bottom, respectively). The positions of DRa and DMa
tion with anti-class II serum from digitonin-solubilizedare indicated on the right.
cell fractions from which Percoll had been removed by
ultracentrifugation. To establish not only where the ma-
jority of DM±DR complexes migrated, but also to answerIn a number of experiments described in the remain-
the specific question of whether any class II±DM associ-der of this paper, MAbs have been used to precipitate
ation occurred in the ER, the class II±DM immunoprecip-DM±DR complexes. The specificities of these antibodies
itates were treated with endoglycosidase H before anal-have all been determined at neutral pH and two, 1B5
ysis by SDS±PAGE. For comparison, endo H-digestedand 16.23, do not bind under acidic conditions. For the
unprecipitated subcellular material from the same frac-sake of consistency, pH 7 lysis conditions were em-
tions was analyzed in parallel. Most DM±DR complexesployed in all subsequent experiments where material
were found in fraction 12 (Figure 4B). Examination of
immunoprecipitated by anti-DR reagents was ex-
precipitated material revealed some fully endo H-sensi-
amined.
tive, and, therefore, ER resident DMa in fraction 2, indi-
cating that this was the position on the gradient to which
DM±DR Complexes Are Not Generated ER membranes migrated. In this same fraction, even on
After Cell Lysis prolonged exposure, very little DR-associated HLA-DM
The coimmunoprecipitation of DM and DR molecules was visible and all exhibited the partial endo H resis-
from cell lysates (Figure 2) suggests that these com- tance of mature DMa. Thus, we were unable to detect
plexes exist in vivo. To eliminate the possibility that the DM±DR complexes in the ER. The presence of some
observed DM±DR complexes were the result of postlysis DM±DR complexes in intermediate density fractions is
association, digitonin extracts from the DMb2 mutant consistent with an endosomal localization. A similar dis-
7.9.6 and from the DRa2 mutant HMy2. DRN were mixed tribution of DM±DR complexes was seen when subcellu-
and then analyzed for DM±DR association in vitro. Con- lar fractions were lysed at acidic pH, indicating that the
current analyses of individual lysates from these cell relative instability of the complex at pH 7 had not af-
lines and from Raji served as controls. To avoid con- fected the analysis.
founding the results by precipitating DPaDRb or
DQaDRb heterodimers, the anti-DRa-specific MAb 1B5 DM Heterodimers Interact with DR Molecules
was used instead of anti-DR serum. A lysis pH of 7 was Recognized by the Conformation-Dependent
used with the 1B5 MAb as it precipitates inefficiently MAb 16.23
under acidic conditions. Figure 3 shows that while both It was of interest to determine the stage in the peptide
loading process during which DM and DR moleculesDM and DR could be immunoprecipitated individually
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Figure 4. DM/DR Complexes Are Not De-
tected in the ER
(A) Migration of DR- and DM-containing sub-
cellular compartments on Percoll density gra-
dient. Raji cells were disrupted, and postnu-
clear material fractionated by Percoll density
gradient centrifugation. Fractions were ana-
lyzed by SDS±PAGE and Western blotting.
Class I heavy chain, DRa, and DMa were de-
tected with MAbs HC10, 1B5, and 5C1, re-
spectively. Their positions are indicated on
the right. Fractions are numbered 0±12, start-
ing at the top (least dense area) of the gra-
dient.
(B) In a separate experiment, subcellular frac-
tions were solubilized in digitonin at pH 7 and
Percoll removed by ultracentrifugation. Mate-
rial was then immunoprecipitated with anti-
DR serum. These immunoprecipitates, to-
gether with untreated samples of the same
set of subcellular fractions, were digested
with endoglycosidase H. Analysis was by
SDS±PAGE and immunoblotting. Undigested
total cell lysate (R) was loaded to the left, as
a control. The blots were probed with MAb
to DMa (5C1). Fraction numbers are indicated
along the top. Locations of fully glycosylated
DMa (M) and of partially endo H-resistant (P)
and fully endo H-sensitive (S) forms are indi-
cated on the right.
interact. An approach to this problem is to use confor- chain was detected in these same immunoprecipitates,
even on prolonged exposure of the probed filters (datamation-dependent class II antibodies for coimmuno-
precipitation. HLA-DM was immunoprecipitated both by not shown), verifying the proposed specificities of the
reagents for mature DR molecules. To show that matureMAb L243, which recognizes ab heterodimers but not
abIi complexes and by MAb 16.23, which is thought to DR heterodimers isolated by MAb 16.23 and L243 were
interacting with DM heterodimers and not just with DMarecognize only the peptide-bound form of DR3 (Mellins
et al., 1991) (Figure 5, lanes marked with asterisk). Lack alone, the DM±DR complexes were disrupted with NP40.
DMab heterodimers were successfully precipitated fromof recovery of HLA-DM or HLA-DR from cells expressing
other DR allotypes (i.e., not DR3), or from DMb2 mutant the NP40 eluate using DMb polyclonal serum, as was
shown by the reactivity of MAb 5C1 with immunoprecipi-cells, confirmed the specificity of the 16.23 antibody
under the conditions used and discounted the possibil- tated material on the Western blot.
ity that HLA-DM might have been directly immunopre-
cipitated by this MAb (data not shown). In addition, no Ii Migration of DM±DR Complexes on Sucrose
Velocity Gradient Centrifugation
To determine the stochiometry of the association be-
tween HLA-DM and HLA-DR, dense subcellular frac-
tions of Raji cells, where DM±DR complexes accumu-
late, were solubilized in digitonin and analyzed by
sucrose velocity gradient centrifugation. Figure 6A
shows the distribution of DM and DR molecules after
16 hr of centrifugation. HLA-DM apparently migrated
slightly faster than HLA-DR, with a peak concentration
one fraction further away from the meniscus (fractions
7/8 versus 6/7). To look for DM±DR complexes, DM- and
DR-containing fractions (6±12) were further analyzed byFigure 5. DMab Heterodimers Are Associated with Mature Class II
immunoprecipitation with anti-DR and anti-DMb seraMolecules
(Figure 6B). Migration of DR molecules in the anti-DRThe conformational-specific MAb 16.23 and MAb L243, which rec-
immunoprecipitates (Figure 6B, top) and of DM mole-ognize mature DR heterodimers, were used to immunoprecipitate
from Raji cells solubilized in digitonin at pH 7. After washing, one- cules in anti-DM isolates (bottom) essentially paralleled
fifth of the immunoprecipitate was loaded directly onto a polyacryl- the distribution seen in Figure 6A, with a longer exposure
amide gel (asterisk). Of the beads, four-fifths were incubated over- (data not shown) of the blot in the top panel revealing
night with NP40 lysis buffer in order to elute HLA-DM. Material small amounts of HLA-DR in fractions 9±11. The sedi-
immunoprecipitated from the NP40 eluate by anti-DMa, (FS1); anti-
mentation rate of class II±associated DM molecules es-DMb (AK3), or by an irrelevant (anti-LMP 7) control serum, was
tablished by probing the anti-DR blot with anti-DMaloaded in adjacent lanes as indicated. The resulting Western blot
was probed with MAb 5C1 to detect DMa. MAb 5C1 was greater (peak in fraction 9) than that of
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a result, the amount of coprecipitated HLA-DM ceased
to be directly comparable between samples from the
two cell lines. To circumvent this problem, the amounts
of solubilized fraction 12 from B LCL 5.1 that were used
as substrate for immunoprecipitation were scaled down
by factors of 5 (Figure 7, lane 4) and 10 (lane 5). We
were now recovering more HLA-DRfrom 10.24.6 fraction
12 than from the adjusted 5.1 fraction (Figure 7, top,
lanes 8 and 4, respectively). Despite this, coisolated
HLA-DM, although easily seen in the wild-type cell (Fig-
ure 7, bottom, lane 4) was barely detectable in the mu-
tant cell (lane 8, bottom).
HLA-DM Interacts with the Ii Chain in the
ER and in Lysosomal Compartments
Class II molecules leave the ER in a nonameric complex
with Ii. This complex is then directed by targeting signals
in the Ii cytoplasmic tail to a post-Golgi compartment
Figure 6. Sedimentation Behavior of DR±DM Complexes where Ii is proteolytically degraded. In the absence of
The densest subcellular fraction separated by Percoll density gradi- HLA-DM, the smallest Ii proteolytic fragment CLIP re-
ent centrifugation, was solubilized in 1% digitonin at pH 7, spun at mains bound to the class II molecule. Recent studies
100,000 3 g for 1 hr to remove the Percoll and proteins fractionated have indicated that DM catalyzes the exchange of CLIP
on a sucrose velocity gradient.
for antigenic peptides in vitro (Denzin and Cresswell,(A) Distribution of DRa (blot probed with IB5) and DMa (blot probed
1995; Sherman et al., 1995; Sloan et al., 1995). To deter-with 5C1) after sucrose gradient centrifugation. The migration posi-
mine whether HLA-DM might interact with Ii directly, wetions of sedimentation markers are indicated with arrows.
(B) Samples from fractions found to contain DM and DR molecules adopted an approach similar to the one used for MHC
(i.e., numbers 6±11) were incubated overnight with protein class II. In addition, the tripeptide protease inhibitor leu-
A±Sepharose coupled to anti-DR serum or to anti-DMb serum. Im- peptin, which leads to the accumulation of N-terminal
munoprecipitates were analyzed by SDS±PAGE and Western blot-
intermediates of Ii proteolysis, was used to facilitate theting. The blots were probed with MAbs to DRa (1B5) or to DMa
investigation of possible interaction between HLA-DM(5C1). The precipitating antibody is indicated to the left, and the
and Ii fragments. Raji, 7.9.6 (DMb2), and 2.2.93 (DMa2)locations of class II and DM a chains, to the right of each strip.
Fractions are numbered from 1, at the top of the gradient, to 15, at cells were cultured in the presence or absence of leu-
the bottom. peptin and extracted in 1% digitonin at pH 7. Ii-specific
antibody VICY1 (which is directed against a cytoplasmic
epitope and so will recognize both intact Ii and its N-
the bulk of either HLA-DM or of HLA-DR. Comparison terminal proteolytic fragments) and Bu45 (which binds
with standard markers indicated a sedimentation coeffi- to an epitope near the C terminus that is absent from Ii
cient for the complexes of around 10S. This is slightly proteolytic intermediates) were used for immunoprecipi-
less than that observed for abIi nonamers (Roche et al., tation. Isolates were analyzed by SDS±PAGE, and coim-
1991). munoprecipitated HLA-DM was detected with the DMa
MAb 5C1. Immunoprecipitates from leupeptin-treated
and from untreated Raji cells were divided and one-halfAssociation of HLA-DM and HLA-DR Is
Reduced in the Glycosylation digested with endo H prior to analysis. HLA-DM was
coimmunoprecipitated with Ii by either MAb (Figure 8A).Mutant 10.24.6
The presence of an additional N-linked glycosylation In the absence of leupeptin, Ii-associated DMa (lower
of bands marked U) was fully endo H sensitive (S). Asite in the DR a chain in the 10.24.6 (DR3-Ser96) mutant
results in a phenotype similar to that of DM2 cells in DMa band of a similar mobility was coprecipitated by
either of the Ii MAbs from 7.9.6 lysates, whether or notthis DM1 cell line (Mellins et al., 1994). Purified soluble
HLA-DM is unable to catalyze the removal of CLIP from cells had been pretreated with leupeptin. This confirmed
the ER location of the endo H-sensitive DMa band (thethe mutant DR molecules in vitro (Sloan et al., 1995),
suggesting that unlike native DR3, DR3-Ser96 is not able DM a chains in the mutant cells are unpaired and so
unable to leave the ER) and indicated that unpaired DMto associate with HLA-DM. To test this hypothesis, we
looked for class II±associated HLA-DM in the 10.24.6 a chains were able to associate with Ii. In this context,
it is noteworthy that no DMa was detected in anti-DRcell line (Figure 7). 10.24.6 mutant and 5.1 wild-type cells
were fractionated on Percoll density gradients. SDS± immunoprecipitates from 7.9.6 cells (data not shown),
indicating that unlike Ii, HLA-DR can only associate withPAGE and Western blotting were employed to analyze
representative fractions, both directly (Figure 7, lanes DM heterodimers. After leupeptin pretreatment lower
mobility, partially endo H-resistant forms of DMa9±14), and after immunoprecipitationwith anti-DR serum
(lanes 1±8). In pilot experiments, we noted that consider- (marked P) were coprecipitated, but only by VICY1, not
by Bu45.ably more DRa was precipitated from the dense Percoll
gradient fraction (number 12) of the 5.1 cells as com- The coprecipitation by MAb VICY1 but not by MAb
Bu45, of mature forms of DMa from leupeptin pretreatedpared with the same fraction of 10.24.6 mutant cells. As
Immunity
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Figure 7. The Interaction Between Class II
and HLA-DM Is Weaker in the DRa Glycosyla-
tion Mutant 10.24.6
10.24.6 (mutant) and 5.1 (homozygous wild-
type) B cells were subjected to subcellular
fractionation on a Percoll density gradient.
Samples of three fractions from representa-
tive regions of the gradient were lysed in dig-
itonin at pH 7, spun at 100,000 3 g for 1 hr
to remove the Percoll, and then incubated
for 3 hr with protein A±Sepharose coupled
to anti-DR serum. These immunoprecipitates,
as well as samples of the same fractions that
had not been subjected to immunoprecipita-
tion, were analyzed by SDS±PAGE and West-
ern blotting. Lanes 12* and 12 show material
precipitated by anti-DR serum from 1:5 and
1:10 dilutions, respectively, of the solubilized
fraction 12 from the 5.1 cells. Identical blots
were probed with MAbs to DRa (1B5) and
DMa (5C1). The positions of DRa and DMa
are marked on the right.
Figure 8. HLA-DM Associates with Ii in the ER and with Proteolytic Fragments of Ii in the MIIC
(A) Raji cells and 2.2.93 and 7.9.6 mutant cells were cultured in the presence or absence of leupeptin as indicated and lysed in 1% digitonin,
30 mM Tris±HCl (pH 7). Material was immunoprecipitated from these lysates using the anti-Ii MAbs Bu45 (recognizing a luminal epitope of
the molecule) and VICY1 (which binds an epitope near the N terminus that is preserved in Ii proteolytic fragments). The Raji cell immunoprecipi-
tates were divided, and half the sample was digested with endoglycosidase H. All immunoprecipitates were analyzed by 12%±8% gradient
SDS±PAGE and Western blotting. The blots were probed with MAb against DMa (5C1). The positions of undigested DMa (U) and of partially
resistant (P) and endo H-sensitive forms (S) of DMa are indicated on the right.
(B) Raji cells cultured in the presence (1L) or absence (2L) of leupeptin were fractionated on Percoll density gradients. The distribution of
class II, class I, and DM across both sets of fractions (which were collected by hand) was similar to that shown in Figure 4A, with the exception
that in this experiment the ER and surface membranes were found in fraction 3 (data not shown). Fractions 3, 7, and 12, corresponding to
ER/plasma membrane, intermediate density, and lysosomal compartments, respectively, were lysed in digitonin pH 7 and centrifuged at
100,000 3 g for 1 hr to remove the Percoll. These lysates were then incubated with protein A±Sepharose coupled to either MAb Bu45 or to
MAb VICY1 and the immunoprecipitates analyzed by SDS±PAGE and Western blotting. The blot was probed with MAb to DMa (5C1). The
positions of mature (M) and immature (I) DMa are marked on the right.
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cells, pointed to association of N-terminal Ii fragments implicates the additional carbohydrate group of DR3-
Ser96 in sterically inhibiting interaction of HLA-DM withwith HLA-DM. Proteolytic fragments of Ii chain have
been detected in association with HLA-DR in dense Per- the lateral face of the class II molecule. Furthermore,
it supports the contention that a direct association iscoll gradient fractions (Maric et al., 1994). To localize
DM±Ii-fragment complexes, we analyzed leupeptin- required for normal MHC±class II peptide loading.
In APCs, HLA-DMaccumulates intracellularly togethertreated and untreated Raji cells by subcellular fraction-
ation. Fraction 3, containing ER and surface mem- with class II molecules in a specialized lysosomal/endo-
somal vesicle termed the MIIC (Sanderson et al., 1994).branes, fraction 7, and the densest fraction, number 12,
were solubilized in digitonin and subjected to immuno- Figure 4 shows that DM±DR complexes are found pre-
dominantly within dense subcellular fractions. The com-precipitation with VICY1 or BU45 followed by SDS±
PAGE and immunoblotting (Figure 8B). Mature DMa (M) plexes have similar sedimentation properties on Percoll
gradients to the MIIC and to a compartment where, afterwas again restricted to VICY1 immunoprecipitates and
again only if the cells had been pretreated with leupep- incubation with extracellular protein antigen, loaded
class II molecules first appear (Qiu et al., 1994). Consis-tin. The DM±Ii-fragment complexes detected in this way
were found uniquely in the dense Percoll gradient frac- tent with the proposed catalytic nature of the DM±DR
interaction, there was no detectable association be-tion (number 12). Using MAb VICY1 to probe a Western
blot of the same immunoprecipitates, analyzed this time tween the two molecules in the ER (Figure 4) or between
HLA-DR and isolated ER-confined DM a chains in theby 18% SDS±PAGE, we were able to confirm that full-
length Ii was present in ER fractions and that a p12 DMb2 mutant 7.9.6 (data not shown). However, we were
able to detect some DM±DR complexes in intermediateIi fragment was recovered in the VICY1 precipitate of
fraction 12 from leupeptin-pretreated cells (data not density Percoll gradient fractions, a finding which sup-
ports the suggestion that multiple endocytic compart-shown).
ments may participate in peptide loading (Castellino and
Germain, 1995).
Discussion DR abCLIP has been proposed as the substrate for
HLA-DM in wild-type cells (Denzin and Cresswell, 1995;
Published data relating to the function of HLA-DM indi- Sherman et al., 1995; Sloan et al., 1995). We were sur-
cate that it must be intact for efficient presentation by prised to discover that HLA-DM is efficiently coprecipi-
B cells of Ii-dependent antigens; that when HLA-DM is tated with DR molecules recognized by the conforma-
absent most class II molecules appear on the cell sur- tion-specific MAb 16.23. This antibody has been used
face as the abCLIP processing intermediate and that to characterize DM-deficient mutant cell lines and is
release of CLIP or of the leupeptin-induced protein (LIP) thought to recognize only peptide-loaded DR3 mole-
from ab complexes is induced by HLA-DM under acidic cules (Mellins et al., 1991). It does not react with abCLIP
conditions in vitro (Denzin and Cresswell, 1995; Sherman or with abIi. Whether the isolation of HLA-DM with MAb
et al., 1995; Sloan et al., 1995). One possible explanation 16.23 indicates an association between HLA-DM and
for these data is that there is a physical interaction be- peptide-bound DR molecules is unclear. It is possible
tween HLA-DM and precursors of the mature HLA-DR± that this conformation-specific antibody recognizes, in
peptide complex. We have shown that DM and DR mole- addition to DR3-peptide, DM-bound DR3 immediately
cules are coprecipitated from cellular or subcellular following the release of CLIP. Either hypothesis implies
material that has been solubilized in digitonin. The fact that HLA-DM is able to interact with DR conformers
that no association was evident in detergents such as other than abCLIP, consistent with the demonstration
NP40 indicates a relatively weak interaction. Further- by Denzin and Cresswell that HLA-DM increases the
more, the enhanced association of the two molecules efficiency with which peptide is loaded onto empty DR
at low pH is consistent both with the requirement for an molecules in vitro.
acidic environment demonstrated for HLA-DM-medi- We also searched for evidence of a physical interac-
ated CLIP release in vitro (Denzin and Cresswell, 1995; tion between HLA-DM and abCLIP. Using the MAb Cer-
Sherman et al., 1995; Sloan et al., 1995) and with the CLIP, which recognizes an epitope at the N terminus of
conditions in the peptide-loading compartment. CLIP as it lies within the class II groove, we were unable
The most persuasive evidence implicating direct to coimmunoprecipitate HLA-DM (data not shown). One
physical interaction between HLA-DM and HLA-DR interpretation of this negative result is that an associa-
comes from the study of the mutant cell line 10.24.6 tion between HLA-DM and abCLIP, if present, is fleeting
(Mellins et al., 1994). DR molecules in these cells have in nature. A second possibility, that HLA-DM and Cer-
an additional N-linked glycan at position 94 in the a2 CLIP binding are mutually exclusive, is suggested by
domain and despite normal levels of HLA-DM exhibit a the inhibitory effect of the CerCLIP antibody on DM-
DM2 phenotype: the mutant DR ab heterodimers are induced CLIP dissociation in vitro (Denzin and Cress-
unable to present intact protein antigens and accumu- well, 1995).
late instead as abCLIP complexes. Despite appropriate Data from in vitro studies raises the possibility that
in vitro conditions, HLA-DM fails to catalyze the dissoci- the physiological substrate for HLA-DM may not be ab-
ation of CLIP from abCLIP isolated from the mutant CLIP but ab bound to one of the longer Ii chain proteo-
cell line (Sloan et al., 1995). We have demonstrated a lytic intermediates, theso-called leupeptin-induced pro-
dramatic reduction in HLA-DR-associated DM mole- tein LIP (Denzin and Cresswell, 1995). We have shown
cules in vivo in the 10.24.6 mutant cells as compared that HLA-DM can be recovered together with leupeptin-
induced Ii fragments (Figure 8). The coisolated HLA-DMwith the wild-type control (Figure 7). This finding clearly
Immunity
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is endo H resistant and is found in the same dense ªemptyº molecule, by virtue of its continued association
with HLA-DM. The question of the exact stage at whichPercoll gradient fractions as the Ii chain fragments them-
selves and as DM±DR complexes. These findings raise HLA-DM dissociates, and whether dissociation is pro-
moted by peptide binding or by some other signal, re-the possibility that HLA-DM might associate not with
abCLIP but with abLIP, which may be its physiological mains to be resolved.
substrate in vivo. An alternative explanation is that DM
Experimental Proceduresmolecules bind to DR ab and proteolytic fragments of
Ii independently. Ii-associated HLA-DM is also detected
Cell Linesin the ER where no DM±DR complexes are found, sug-
Raji is a wild-type Burkitt lymphoma cell line. The 5.1 B -LCL and
gesting that here HLA-DM associates with full-length Ii, mutant 2.2.93 (Fling et al., 1994) were provided by Dr. D. Pious
in complexes from which DR molecules are absent. (Seattle, Washington), mutant 7.9.6 (Morris et al., 1994) and 10.24.6
In ourexperiments, we have considered the possibility (Mellins et al., 1994) by Dr. E. Mellins, (University of Pennsylvania,
Philadelphia). HMy2.DRN (Koppelman and Cresswell, 1990) wasthat the association we observe is due to nonspecific
provided by Dr. P. Travers, (Imperial Cancer Research Fund, Lon-interactions or clumping of material, or to trapping of
don). The cell lines were maintained in RPMI with 5% calf serum inDM and DR molecules within incompletely solubilized
the presence of 5% CO2 at 378C.membranes. Figure 3 shows that DM±DR complexes are
not detected unless both molecules are derived from Antibodies
the same cell, indicating that aggregation of proteins in The MAb 5C1 was made by immunizing mice with recombinant
protein corresponding to the a1 and a2 domains of DMa (Sandersonvitro within the lysate is not responsible for their ob-
et al., 1994). The hybridoma cell lines 16.23 (anti-HLA-DR3) (Piousserved coprecipitation in our system. A further implica-
et al., 1985), L243 (anti-DRab) (Lampson and Levy, 1980), 1B5 (anti-tion of these data is that the in vitro conditions used
DRa) (Adams et al., 1983), and HC10 (anti-MHC class I heavy chain)are inappropriate for formation of physiological DM±DR (Stam et al., 1986) have been described elsewhere, as have the
complexes. This presumably reflects the different nature rabbit antisera AK3 (anti-DMb) (Sanderson et al., 1994) and the anti-
of the in vivo and in vitro environments and particularly DR serum (Neefjes et al., 1990). VICY1 (anti-Ii chain N terminus)
(Quaranta et al., 1984) was provided by ProfessorW. Knapp (Vienna),the presence in vivo of both proteins within the same
Bu45 (anti-Ii, luminal portion) (Wraight et al., 1990) by Professor N.cellular membrane and at high local concentration. The
Koch (Bonn), and CerCLIP (anti-CLIP24) (Denzin et al., 1994) bysucrose gradient centrifugation experiments were de-
Professor P. Cresswell (Yale University).
signed to investigate the possibility that HLA-DM and
HLA-DR were coprecipitated from aggregates or mem- Glycoprotein Preparations
brane fragments that had not been removed from digito- Glycoproteins were extracted from NP40-solubilized cells with lentil
nin-solubilized materialby ultracentrifugation. Using this lectin Sepharose (Pharmacia) and eluted with 1 M methyl D manno-
side in phosphate-buffered saline as previously described (San-technique, HLA-DR-associated DM molecules migrate
derson et al., 1994).with a velocity inconsistent with their presence in a com-
plex larger than 300 kDa (Figure 6).Membrane fragments
Immunoprecipitation and SDS±PAGE
quickly migrate through sucrose gradients to reach an Cells were lysed at 2 3 106±107/ml in Tris±HCl (pH 7) or sodium
equilibrium position that is determined by their density. acetate (pH 5) buffer containing 1% digitonin (Sigma) or 1% NP40
The DM±DR complexes that we detected continued to (GIBCO BRL) and 1 mM PMSF. The lysates were precleared twice
with protein A±Sepharose (PAS) (Pharmacia) and then incubated atmove down the gradient when the length of spin was
48C with antibody-coupled PAS for 2±5 hr, unless otherwise stated.extended beyond 16 hr (data not shown), indicating that
Antisera were coupled directly to PAS and MAbs to PAS that hadthey were not trapped within incompletely solubilized
been preincubated with rabbit anti-mouse antibodies (Dako) by ro-
membranes. We also noted that the bulk of DM±DR tating at 48C for 2 hr or overnight at RT. Immunoprecipitates were
complexes migrated faster and were isolated from frac- washed once with lysis buffer, three times with buffer containing
tions further from the meniscus than those containing 0.25% digitonin, and once with water and stored at 2208C until use.
For immunoprecipitation from Percoll gradient fractions, fraction-most of the HLA-DM and the majority of the HLA-DR.
ated material was solubilized using 23 lysis buffer supplementedThis pattern is clearly very different to that which would
with 2% bovine serum albumin and the Percoll removed by centrifu-result from an indiscriminate recovery of HLA-DM by
gation at 100,000 3 g for 1 hr prior to the preclearing step. Immuno-
anti-DR serum and provides additional evidence for the precipitates were eluted in Laemmli sample buffer, analyzed by
specificity of interactions detected in our system. SDS±PAGE (11% gels, unless otherwise indicated), and transferred
We would like to propose the following as a scheme onto PVDF membranes (Immobilon, Millipore). Membranes were
blocked in 5% skimmed milk. Antibody binding was detected byconsistent with the observed interactions between HLA-
incubation with horseradish peroxidase±conjugated rabbit anti-DM and HLA-DR and between HLA-DM and Ii: DM asso-
mouse (Dako) followed by enhanced chemiluminescence (Am-ciates with Ii in the ER and travels with it to a post-Golgi
ersham).
compartment. Here, intact Ii dissociates or is partially
degraded prior to dissociation in much the same way Two-Dimensional PAGE
as Ii in DR abIi complexes. Another fraction of DM may Two-dimensional gel analysis with NEPHGE (5±7 and 3.5±10 Ampho-
be targeted to MIIC via a signal in the cytoplasmic tract lines, Pharmacia Biotech) in the first dimension and 11% SDS±PAGE
in the second dimension was performed using the BioRad minigelof DMb. Here, HLA-DM is able to associate with class II
apparatus according to the instructions of the manufacturer.abCLIP or abLIP. Under the prevalent acidic conditions,
this association induces a conformational change in the
Subcellular Fractionation
DR ab heterodimer that results in its dissociation from Cells (1±2 3 108) were washed and disrupted in 2.5 ml of ice cold
the Ii fragment (be it CLIP or LIP) and the acquisition of homogenization buffer (0.25 M sucrose, 10 mM triethanolamine,
a state that is now favorable to the binding of antigenic 1 mM EDTA, 10 mM acetic acid, 10 mg/ml leupeptin, 1 mM PMSF,
[pH 7.4]) using a ball-bearing homogeniser (Berni-Tech Engineering,peptide. The new conformation is maintained in the
DM±DR Association
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Incorporated). The homogenate was incubated for 10 min at room are both required for MHC class II/peptide complex formation in
antigen-presenting cells. Nature 368, 554±558.temperature with DNase I to a final concentration of 100 mg/ml.
Postnuclear supernatant was prepared by low speed centrifugation Germain, R.N. (1994). MHC-dependent antigen processing and pep-
(2,000 3 g for 10 min at 48C) and then layered onto 20% Percoll in tide presentation: providing ligands for T lymphocyte activation. Cell
homogenization buffer. Centrifugation was carried out in a 70.1 Ti- 76, 287±299.
fixed angle rotor (Beckman) for 20 min at 19,000 rpm and 48C.
Karlsson, L., Peleraux, A., Lindstedt, R., Liljedahl, M., and Peterson,
Fractions of 1 ml were judged by eye and collected from the bottom
P.A. (1994). Reconstitution of an operational MHC class II compart-
of the gradient.
ment in nonantigen-presenting cells. Science 266, 1569±1573.
Kelly, A.P., Monaco, J.J., Cho, S., and Trowsdale, J. (1991). A newSucrose Density Gradient Centrifugation
human HLA class II±related locus, DM. Nature 353, 571±573.Digitonin-solubilized material (700 ml) from the appropriate Percoll
Koppelman, B., and Cresswell, P. (1990). Rapid nonlysosomal deg-gradient fraction was centrifuged at 100,000 3 g to remove the
radation of assembled HLA class II glycoproteins incorporating aPercoll, and the supernatant layered onto linear 8%±25% sucrose
mutant DR a-chain. J. Immunol. 145, 2730±2736.gradients in 50 mM Tris, 0.3% digitonin (pH 7.0) at 48C. Centrifuga-
tion was at 39,000 rpm for 16 hr in a Beckman-type SW40.1 rotor Lamb, C.A., and Cresswell, P. (1992). Assembly and transport prop-
at 78C. Fractions (900 ml) were collected from the top of the gradient. erties on invariant chain trimers and HLA-DR±invariant chain com-
The sedimentation markers bovine serum albumin (4.6 S), immuno- plexes. J Immunol. 148, 3478±3482.
globulin G (7 S), and thyroglobulin (18 S) were applied to separate Lampson, L.A., and Levy, R. (1980). Two populations of la-like mole-
gradients. cules on a human B cell line. J. Immunol. 125, 293±299.
Lotteau, V.,Teyton, L., Peleraux,A., Nilsson,T., Karlsson,L., Schmid,
Leupeptin and Endoglycosidase H Treatments
S.L., Quranta, V., and Peterson, P.A. (1990). Intracellular transport
The cell suspension at 0.5 3 106 cells per ml was divided into two,
of class II MHC molecules directed by invariant chain. Nature 348,
and leupeptin (Sigma) was added to one-half at a final concentration
600±605.
of 100 mM, 16 hr prior to cell lysis/fractionation.
Maric, M.A., Taylor, M.D., and Blum, J.S. (1994). Endosomal asparticFor endoglycosidase H treatment, the immunoprecipitate or Per-
proteinases are required for invariant chain processing. Proc. Natl.coll gradient sample was denatured by boiling for 3 min in 50 mM
Acad. Sci. USA 91, 2171±2175.sodium acetate, 0.3% SDS (pH 5). The sample was incubated with
10 ml (10 mU) of endogycosidase H (Boehringer Mannheim) at 378C, Marks, M.S., Blum, J.S., and Cresswell, P. (1990). Invariant chain
trimers are sequestered in the rough endoplasmic reticulum in theovernight.
absence of association with the HLA class II antigens. J. Cell Biol.
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